Insider Trading: Illumina Inc (ILMN.O)
ILMN.O on Nasdaq
70.59USD
3:05pm EDT
70.59USD
3:05pm EDT
Price Change (% chg)
$-1.99 (-2.74%)
$-1.99 (-2.74%)
Prev Close
$72.58
$72.58
Open
$72.38
$72.38
Day's High
$72.68
$72.68
Day's Low
$70.48
$70.48
Volume
1,700,341
1,700,341
Avg. Vol
1,355,933
1,355,933
52-wk High
$77.11
$77.11
52-wk Low
$37.77
$37.77
| FLATLEY JAY T | Options Exercised: 0 | ||
| Trade Date: | Wednesday, 23 Jan 2013 | Price: | 50.79 |
| Title: | Chief Executive Officer | Shares Held: | 409,357 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 438 |
| Total Shares Held: | 143,882,772 |
| 3 Mo. Net Change: | -281,934 |
| # New Positions: | 38 |
| # Closed Positions: | 62 |
| # Increased Positions: | 179 |
| # Reduced Positions: | 202 |
| # Net Buyers: | -23 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
William Rastetter |
64 | 2005 | Chairman of the Board |
Jay Flatley |
60 | 1999 | President, Chief Executive Officer, Director |
Marc Stapley |
43 | 2012 | Chief Financial Officer, Senior Vice President |
David Walt |
60 | 1998 | Chairman - Scientific Advisory Board, Independent Director |
Mostafa Ronaghi |
44 | 2008 | Chief Technology Officer, Senior Vice President |
Charles Dadswell |
2013 | Senior Vice President, General Counsel, Secretary | |
Gregory Heath |
55 | 2008 | Senior Vice President, General Manager - Diagnostics |
Christian Henry |
45 | 2012 | Senior Vice President, General Manager - Genetic Analysis |
Mark Lewis |
60 | 2012 | Senior Vice President, General Manager - Molecular Biology and PCR |
Matthew Posard |
46 | 2012 | Senior Vice President, General Manager - Translational and Consumer Genomics |
Paul Bianchi |
51 | 2012 | Senior Vice President - Human Resources |
Nicholas Naclerio |
40 | 2011 | Senior Vice President - Corporate and Venture Development |
Tristan Orpin |
47 | 2010 | Chief Commercial Officer, Senior Vice President |
A. Blaine Bowman |
66 | 2007 | Independent Director |
Daniel Bradbury |
51 | 2004 | Independent Director |
Karin Eastham |
63 | 2004 | Independent Director |
Robert Epstein |
57 | 2012 | Independent Director |
Paul Grint |
2005 | Independent Director | |
Gerald Moller |
69 | 2010 | Independent Director |
Roy Whitfield |
59 | 2007 | Independent Director |
Rebecca Chambers |
Senior Director - Investor Relations |

